Hancom Lifecare Future Growth
Future criteria checks 3/6
Hancom Lifecare is forecast to grow earnings and revenue by 25.2% and 13.6% per annum respectively. EPS is expected to grow by 25.4% per annum. Return on equity is forecast to be 8.4% in 3 years.
Key information
25.2%
Earnings growth rate
25.4%
EPS growth rate
| Commercial Services earnings growth | 9.6% |
| Revenue growth rate | 13.6% |
| Future return on equity | 8.4% |
| Analyst coverage | Low |
| Last updated | 18 Aug 2024 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 167,700 | 13,900 | 4,900 | 11,800 | 1 |
| 12/31/2025 | 147,000 | 11,200 | 7,400 | 13,500 | 1 |
| 12/31/2024 | 130,700 | 10,200 | -8,000 | -2,700 | 1 |
| 6/30/2024 | 118,566 | 6,423 | -21,947 | -18,714 | N/A |
| 3/31/2024 | 117,798 | 2,332 | -10,590 | -6,422 | N/A |
| 12/31/2023 | 112,780 | 825 | -13,823 | -8,466 | N/A |
| 9/30/2023 | 107,465 | 7,821 | -4,853 | 1,548 | N/A |
| 6/30/2023 | 106,940 | 8,510 | 24,791 | 32,248 | N/A |
| 3/31/2023 | 93,666 | 9,394 | 5,552 | 12,105 | N/A |
| 12/31/2022 | 100,120 | 9,204 | -1,055 | 5,082 | N/A |
| 9/30/2022 | 99,895 | 162 | 13,440 | 18,949 | N/A |
| 6/30/2022 | 98,810 | -1,715 | 1,847 | 5,499 | N/A |
| 3/31/2022 | 113,757 | 372 | 11,365 | 17,750 | N/A |
| 12/31/2021 | 121,140 | 4,835 | 18,462 | 28,051 | N/A |
| 9/30/2021 | 114,708 | 11,046 | 1,982 | 15,686 | N/A |
| 3/31/2021 | 154,073 | 26,923 | -21,031 | 2,304 | N/A |
| 12/31/2020 | 151,842 | 27,690 | -10,737 | 10,385 | N/A |
| 12/31/2019 | 66,586 | -1,791 | 7,896 | 11,265 | N/A |
| 12/31/2018 | 99,008 | 20,434 | 13,491 | 22,246 | N/A |
| 12/31/2017 | 97,770 | 21,150 | N/A | 21,003 | N/A |
| 12/31/2016 | 106,995 | 22,209 | N/A | 31,711 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A372910's forecast earnings growth (25.2% per year) is above the savings rate (2.6%).
Earnings vs Market: A372910's earnings (25.2% per year) are forecast to grow slower than the KR market (28.8% per year).
High Growth Earnings: A372910's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A372910's revenue (13.6% per year) is forecast to grow faster than the KR market (10.6% per year).
High Growth Revenue: A372910's revenue (13.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A372910's Return on Equity is forecast to be low in 3 years time (8.4%).